Exelixis Inc

NASDAQ:EXEL

44.47

-0.40 (-0.89%)

7:43:36 PM EDT: $44.50 +0.03 (+0.07%)

Market Cap (Intraday)	12.13B
Current PE	18.84
Forward PE	16.84
2yr Forward PE	14.16

See more stats

Estimates Current Quarter

Revenue	$576.2 Million
Adjusted EPS	$0.64

See more estimates

10-Day MA	$44.55
50-Day MA	$42.79
200-Day MA	$36.49

See more pivots

Exelixis Inc Stock, NASDAQ:EXEL

1851 Harbor Bay Parkway, Alameda, California 94502

United States of America

Phone: +1.650.837.7000

Number of Employees: 1147

http://www.exelixis.com

Description

Exelixis, Inc. operates as an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.